Compounds > cannabidiol dimethyl ether
Page last updated: 2024-07-31 19:40:08

cannabidiol dimethyl ether

Description

cannabidiol dimethyl ether: metabolite of cannabidiol; structure given in first source [MeSH]

Cross-References

ID SourceID
PubMed CID3081957
CHEMBL ID499322
SCHEMBL ID20658115
MeSH IDM0180901

Synonyms (18)

Synonym
cannabidiol dimethyl ether
1,3-dimethoxy-2-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene
CHEMBL499322
benzene, 1,3-dimethoxy-2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1r-trans)-
mk7ihz7mim ,
1242-67-7
unii-mk7ihz7mim
cbdd
UYBGHBAVRNATET-VQTJNVASSA-N
1,3-dimethoxy-2-[(1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentylbenzene
HMS3648K14
DTXSID00924752
SCHEMBL20658115
SR-01000946383-1
sr-01000946383
22198-90-9
benzene, 1,3-dimethoxy-2-((1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-
1,3-dimethoxy-2-((1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentylbenzene

Bioassays (6)

Assay IDTitleYearJournalArticle
AID362545Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
ISSN: 1520-6025		Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362543Antibacterial activity against tetracycline-resistant Staphylococcus aureus XU212 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
ISSN: 1520-6025		Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362544Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
ISSN: 1520-6025		Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362546Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
ISSN: 1520-6025		Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362542Antibacterial activity against macrolide-resistant Staphylococcus aureus RN4220 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
ISSN: 1520-6025		Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
AID362541Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
ISSN: 1520-6025		Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
cannabinol
1
dibenzopyran2008200816.0low000100
norfloxacin
1
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic		2008200816.0low000100
resorcinol
1
benzenediol;
phenolic donor;
resorcinols		erythropoietin inhibitor;
sensitiser		2008200816.0low000100
oxacillin
1
penicillinantibacterial agent;
antibacterial drug		2008200816.0low000100
olivetol
1
resorcinolslichen metabolite2008200816.0low000100
erythromycin
1
cyclic ketone;
erythromycin		2008200816.0low000100
dronabinol
1
benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic		2008200816.0low000100
cannabichromene
1
1-benzopyran2008200816.0low000100
abnormal cannabidiol
1
monoterpenoid2008200816.0high000100
delta(9)-tetrahydrocannabinolic acid
1
benzochromene;
diterpenoid;
hydroxy monocarboxylic acid;
phytocannabinoid;
polyketide		anti-inflammatory agent;
biomarker;
metabolite;
neuroprotective agent		2008200816.0low000100
cannabidiolic acid
1
dihydroxybenzoic acid;
phytocannabinoid;
polyketide;
resorcinols		2008200816.0low000100
cannabidiol-3-monomethyl ether
1
2008200816.0high000100
cannabidiol
1
olefinic compound;
phytocannabinoid;
resorcinols		antimicrobial agent;
plant metabolite		2008200816.0low000100
cannabigerol
1
phytocannabinoid;
resorcinols		anti-inflammatory agent;
antibacterial agent;
antioxidant;
appetite enhancer;
cannabinoid receptor agonist;
neuroprotective agent;
plant metabolite		2008200816.0low000100
cannabigerolic acid
1
dihydroxybenzoic acid;
diterpenoid;
phytocannabinoid;
polyketide;
resorcinols		2008200816.0low000100
tetracycline
1
2008200816.0low000100
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
masoprocol
1
nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite		2009200915.0low000100
cannabidiolic acid
1
dihydroxybenzoic acid;
phytocannabinoid;
polyketide;
resorcinols		2013201311.0low000010
cannabielsoin
1
1990199034.0medium001000
cannabidiol-3-monomethyl ether
2
1990200924.5high001100
cannabidiol
5
olefinic compound;
phytocannabinoid;
resorcinols		antimicrobial agent;
plant metabolite		1990201516.4medium001130
cerium
1
CE(18:2);
cholesteryl octadeca-9,12-dienoate		human metabolite;
mouse metabolite		2011201113.0low000010
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Atherogenesis0
1
2011201113.0medium000010
Atherosclerosis0
1
2011201113.0medium000010
Breast Cancer0
1
2013201311.0medium000010
Breast Neoplasms0
1
2013201311.0medium000010
Weight Gain0
1
201520159.0medium000010